SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria

Since December 2019 the world has been dealing with a severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) pandemic. The first SARS-CoV-2 vaccine was made available in Europe at the end of 2020. 202 volunteers from the vicinity of the University of Applied Sciences Wiener Neustadt took...

Descripción completa

Detalles Bibliográficos
Autores principales: Mara, Elisabeth, Mader, Tobias, Gratzer, Johannes, Hochegger, Stefanie, Pekar, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472700/
https://www.ncbi.nlm.nih.gov/pubmed/38013972
http://dx.doi.org/10.1016/j.clicom.2022.08.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472700/
https://www.ncbi.nlm.nih.gov/pubmed/38013972
http://dx.doi.org/10.1016/j.clicom.2022.08.001

Ejemplares similares